Marc Van de Casteele
AuthID: R-00H-AKK
1
TITLE: Adaptive Pathways: Possible Next Steps for Payers in Preparation for Their Potential Implementation Full Text
AUTHORS: Patricia Vella Bonanno; Michael Ermisch; Brian Godman; Antony P Martin; Jesper Van den Bergh; Liudmila Bezmelnitsyna; Anna Bucsics; Francis Arickx; Alexander Bybau; Tomasz Bochenek; Marc van de Casteele; Eduardo Diogene; Irene Eriksson; Jurij Fuerst; Mohamed Gad; Ieva Greiciute Kuprijanov; Martin van der Graaff; Jolanta Gulbinovic; Jan Jones; Roberta Joppi; ...More
PUBLISHED: 2017, SOURCE: FRONTIERS IN PHARMACOLOGY, VOLUME: 8, ISSUE: AUG
AUTHORS: Patricia Vella Bonanno; Michael Ermisch; Brian Godman; Antony P Martin; Jesper Van den Bergh; Liudmila Bezmelnitsyna; Anna Bucsics; Francis Arickx; Alexander Bybau; Tomasz Bochenek; Marc van de Casteele; Eduardo Diogene; Irene Eriksson; Jurij Fuerst; Mohamed Gad; Ieva Greiciute Kuprijanov; Martin van der Graaff; Jolanta Gulbinovic; Jan Jones; Roberta Joppi; ...More
PUBLISHED: 2017, SOURCE: FRONTIERS IN PHARMACOLOGY, VOLUME: 8, ISSUE: AUG
INDEXED IN: Scopus WOS
2
TITLE: Payers' Views of the Changes Arising through the Possible Adoption of Adaptive Pathways Full Text
AUTHORS: Michael Ermisch; Anna Bucsics; Patricia Vella Bonanno; Francis Arickx; Alexander Bybau; Tomasz Bochenek; Marc van de Casteele; Eduardo Diogene; Jurij Furst; Kristina Garuoliene; Martin van der Graaff; Jolanta Gulbinovic; Alan Haycox; Jan Jones; Roberta Joppi; Ott Laius; Irene Langner; Antony P Martin; Vanda Markovic Pekovic; Laura McCullagh; ...More
PUBLISHED: 2016, SOURCE: FRONTIERS IN PHARMACOLOGY, VOLUME: 7
AUTHORS: Michael Ermisch; Anna Bucsics; Patricia Vella Bonanno; Francis Arickx; Alexander Bybau; Tomasz Bochenek; Marc van de Casteele; Eduardo Diogene; Jurij Furst; Kristina Garuoliene; Martin van der Graaff; Jolanta Gulbinovic; Alan Haycox; Jan Jones; Roberta Joppi; Ott Laius; Irene Langner; Antony P Martin; Vanda Markovic Pekovic; Laura McCullagh; ...More
PUBLISHED: 2016, SOURCE: FRONTIERS IN PHARMACOLOGY, VOLUME: 7
INDEXED IN: WOS